A GRAIL funded study shows that a liquid biopsy approach might be able to detect early-stage lung cancer.
Starting about 7,000 years ago, and extending over the next two millennia, recent studies suggest, the genetic diversity of men—specifically, the diversity of their Y chromosomes—collapsed.
Japanese scientists now have permission to treat people who have heart disease with cells produced by a revolutionary reprogramming technique, which excites researchers. But some fear the therapy will be rushed to market.
Myriad Genetics has revealed it is acquiring genetic screening firm Counsyl for $375 million.
Fetuses with a specific, rare chromosomal aberration have a 20% risk of developmental or other brain disorder, new research shows. The work could lead to personalised diagnostics and counselling for pregnant women.
J. Craig Venter shared on Twitter last week that he is retiring from Human Longevity, and returning to the J. Craig Venter Institute (JCVI) to continue his work.
A new technique reveals the earliest stages of human development without the need for human embryos.
Chemists have devised a way to rapidly synthesize and screen millions of novel proteins that could be used as drugs against Ebola and other viruses.
A major new analysis reveals for the first time the likely cause of most cases of childhood leukaemia, and that the disease might be preventable.
Lurking quietly in the deep dark jungles of New Guinea are a group of lizards who share a rather striking feature: green blood. It’s a rare trait for vertebrates to have, but new insights into this strange blood could lead to innovative medical treatments.